Pharmaceutical Market: 10 Year Forecast 2016

Language:
Japanese
Product Code No:
C57124400
Issued In:
2016/03
#of Pages:
188
Publication Cycle:
Annual
Format:
PDF

Price

150,000 yen ($970.37)
(excluding consumption tax)
300,000 yen ($1,940.74)
(excluding consumption tax)
450,000 yen ($2,911.11)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 154.58 yen , 2024/04/20 Japan)
*Scope of Each License Type

Coverage: (Product/service)

Pharmaceutical market

Research Target:

hospitals, pharmaceutical wholesalers, dispensing pharmacy chains, other pharmaceutical organizations, and related governmental agencies

Research Content:

I   Medical Service System in Transition Period

  • Reforms toward 2025 steadily becoming larger and larger
  • Number of sickbeds needed in 2025
  • Restructuring needed for hospital sickbeds
  • What will change after local comprehensive care becoming available
  • Pharmacies vacillating

II   Distribution of Medicines in Transitional Period

  • Favorable sales achieved by wholesalers due to special procurement demands for the drugs used to treat hepatitis c infections.
  • Improvement needed in reaching agreement between pharmacies and pharmaceutical companies and in distribution of drugs
  • Wholesalers after the revision of the medical payment system for FY2016
  • How large the Influence of dispending fee revisions to wholesaling business
  • Business management needed to cope with patent cliff

III   Companies of Pharmaceutical Industry in Transitional Period

  • New system to conduct revision every year and large exception to reduce prices for specific drugs with huge sales
  • Long-term listed items that have long been one of characteristics of Japanese pharmaceutical market are to disappear.
  • Existing drugs may be reincarnated as new drugs
  • Can companies make "JPMA Industry Vision 2025" connected with their own growth?
  • M&A should not be the keyword for growth

IV   Drug Market in Transitional Period

  • Great change in development of new drugs
  • Number of patients is likely to continue growing despite no new effective drugs expected to appear
  • Sales forecast of ethical pharmaceuticals in Japan (2015 to 2023)

Price

written in Japanese
150,000 yen ($970.37)
(excluding consumption tax)
300,000 yen ($1,940.74)
(excluding consumption tax)
450,000 yen ($2,911.11)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 154.58 yen , 2024/04/20 Japan)
*Scope of Each License Type